American Shared Hospital Services (NYSEAMERICAN:AMS) Earns Hold Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of American Shared Hospital Services (NYSEAMERICAN:AMS) in a research note published on Saturday. The firm issued a hold rating on the stock.

American Shared Hospital Services Trading Up 1.3 %

Shares of American Shared Hospital Services stock opened at $3.22 on Friday. The company has a market capitalization of $20.38 million, a P/E ratio of 40.26 and a beta of 0.70. American Shared Hospital Services has a fifty-two week low of $2.16 and a fifty-two week high of $3.69. The company has a quick ratio of 1.98, a current ratio of 1.98 and a debt-to-equity ratio of 0.49.

American Shared Hospital Services (NYSEAMERICAN:AMS) last issued its quarterly earnings data on Tuesday, May 14th. The company reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.03 by ($0.01). The business had revenue of $5.22 million during the quarter, compared to analysts’ expectations of $5.01 million. American Shared Hospital Services had a return on equity of 4.29% and a net margin of 2.50%. Research analysts predict that American Shared Hospital Services will post 0.29 earnings per share for the current year.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in American Shared Hospital Services stock. Empowered Funds LLC purchased a new position in shares of American Shared Hospital Services (NYSEAMERICAN:AMS) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 10,468 shares of the company’s stock, valued at approximately $31,000. Empowered Funds LLC owned 0.17% of American Shared Hospital Services as of its most recent SEC filing. Hedge funds and other institutional investors own 23.16% of the company’s stock.

About American Shared Hospital Services

American Shared Hospital Services provides stereotactic radiosurgery and advanced radiation therapy equipment. It operates in two segments, Medical Equipment Leasing, and Retail. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia.